Difference of perceptions and evaluation of cognitive dysfunction in major depressive disorder patients across psychiatrists internationally

Difference of perceptions and evaluation of cognitive dysfunction in major depressive disorder patients across psychiatrists internationally

2014 Ther. Adv. Psychopharmacol

El Hammi, E. | Samp, J. | Remuzat, C. | Auray, J.P. | Lamure, M. | Aballea, S. | Kooli, A. | Akhras, K. | Toumi, M. | Volume: 4, Issue: 1, Pages: 22-29, Depression, Depressive Disorder, France, Germany, Guidance, Spain, Value,

BACKGROUND: Many studies have suggested that major depressive disorder (MDD) is often associated with cognitive dysfunction. Despite this, guidance addressing assessment of cognitive dysfunction in MDD is lacking. The aim of this study was to examine psychiatrists’ perceptions and evaluation of cognitive dysfunction in routine practice in MDD patients across different countries. METHOD: A total of 61 psychiatrists in the US, Germany, France, Spain, Hong Kong, and Australia participated in an online survey about perceptions of cognitive dysfunction in MDD patients, evaluation of cognition and instruments used in cognitive evaluation. RESULTS: Most psychiatrists reportedly relied on patient history interviews for cognitive evaluation (83% in France and approximately 60% in the USA, Germany, Australia and Hong Kong). The remainder used a cognitive instrument or a combination of cognitive instrument and patient history interview for assessment. Of those using instruments for cognitive assessment, only nine named instruments that were appropriate for cognitive evaluation. The remainder reported other clinical measures not intended for cognitive evaluation. CONCLUSIONS: Overall, psychiatrists in routine clinical practice value the assessment of cognitive in MDD. However, there is a lack of standardization in these assessments and misconceptions regarding proper assessment

https://www.doi.org/10.1177/2045125313507946 ;10.1177_2045125313507946 [pii]